Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative acute leukemia cytogenetics.

F Mitelman1, S Heim

  • 1Department of Clinical Genetics, University Hospital, Lund, Sweden.

Genes, Chromosomes & Cancer
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2000
Same author

Karyotypic characterization of urinary bladder transitional cell carcinomas.

Genes, chromosomes & cancer·2000
Same author

Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group.

Histopathology·2000
Same author

Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias.

European journal of haematology·2000
Same author

Survival time in a population-based consecutive series of adult acute myeloid leukemia--the prognostic impact of karyotype during the time period 1976-1993.

Leukemia·2000
Same author

RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).

Genes, chromosomes & cancer·2000
Same journal

PKMYT1 in Cancer: Beyond Cell Cycle Checkpoints to Context-Dependent Therapeutic Vulnerability.

Genes, chromosomes & cancer·2026
Same journal

Associations of Dietary Intake Traits and Aging Indicators With Colorectal Cancer: A Mendelian Randomization Study.

Genes, chromosomes & cancer·2026
Same journal

Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer.

Genes, chromosomes & cancer·2026
Same journal

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Genes, chromosomes & cancer·2026
Same journal

A New Chapter for Genes, Chromosomes and Cancer.

Genes, chromosomes & cancer·2026
Same journal

Detecting Rare ALK Gene Fusions in Unclassified Spindle Cell Lung Tumors Using Anchored Multiplex PCR/Targeted RNA Next-Generation Sequencing.

Genes, chromosomes & cancer·2026
See all related articles

This study quantifies the diagnostic value of chromosomal aberrations in acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Specific genetic markers demonstrate high accuracy in differentiating between these leukemias and their subtypes.

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Cytogenetic abnormalities are crucial in diagnosing and classifying acute leukemias.
  • Understanding the diagnostic utility of specific chromosomal aberrations aids in differential diagnosis.
  • Literature data provides a foundation for evaluating the information value of genetic markers in acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).

Purpose of the Study:

  • To quantify the diagnostic information value of typical ALL- and AML-associated chromosome aberrations.
  • To assess the sensitivity, specificity, and predictive value of these aberrations in various diagnostic scenarios.
  • To aid in the differential diagnosis between ALL and AML, and among their respective subtypes.

Main Methods:

  • Literature data analysis of 3,612 AML cases and 1,551 ALL cases.

Related Experiment Videos

  • Calculation of sensitivity, specificity, and predictive values for specific chromosomal aberrations.
  • Evaluation across diagnostic scenarios: AML vs. ALL, AML FAB subtypes, and ALL FAB subtypes.

    • Main Results:

    • High specificities (close to 1.0) were observed for most aberrations.
    • Key AML sensitivities include +8, t(15;17), t(8;21), and -7; key ALL sensitivities include t(9;22), t(4;11), and +21.
    • Specific aberrations like t(15;17) in M3 AML and t(8;14) in L3 ALL showed high positive predictive values (0.8-1.0).

    Conclusions:

    • Specific chromosomal aberrations possess significant diagnostic value in acute leukemia.
    • These genetic markers are highly effective in differentiating between AML and ALL, and their subtypes.
    • The findings support the use of cytogenetics for precise diagnosis and subclassification in acute leukemia.